Inicio › Cáncer de páncreas › Carolina del Norte
Ensayos clínicos de Cáncer de páncreas en Carolina del Norte
34 estudios sobre Cáncer de páncreas buscan participantes en Carolina del Norte.
Ciudades en Carolina del Norte
Texto oficial del estudio (inglés)
The Vanguard Study: Testing a New Way to Screen for Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06995898Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- FirstHealth of the Carolinas, Pinehurst
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 oct 2026 · NCT07562152Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07059884A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Durham
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07127874Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
- Duke Cancer Center, Durham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07621718DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- University of North Carolina Hospitals at Hillsborough, Hillsborough
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06989437Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Duke Cancer Center, Durham
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07252232A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US035, Chapel Hill
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07522073Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Duke University Medical Center, Durham
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06445062A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0100, Durham
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT07492680Promoting CT Engagement for Pancreatic Cancer With App
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT06252545Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Durham VA Medical Center, Durham
- East Carolina University, Greenville
- y 1 más
ReclutandoEstudio observacional
Edades de 50 a 75 · Todos los sexos · Actualizado el 4 sept 2026 · NCT04239573A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- University of North Carolina, Chapel Hill
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT07644559Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- University of North Carolina - Gastroenterology and Hepatology, Chapel Hill
- University of North Carolina, Chapel Hill
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT05245500Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT06958328Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
- Lineberger Comprehensive Cancer Center, Chapel Hill
ReclutandoFase 1
Edades de 18 a 99 · Todos los sexos · Actualizado el 19 ago 2026 · NCT03454035A Study of DM002 in Patients With Advanced Solid Tumors
- Carolina BioOncology Institute, LLC, Huntersville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT06751329Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
- Levine Cancer Institute, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jul 2026 · NCT05376592Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- Duke University Medical Center, Durham
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jul 2026 · NCT06937177Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Duke Cancer Institute /ID# 276267, Durham
- Carolina BioOncology Institute /ID# 232597, Huntersville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jun 2026 · NCT05005403A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Durham
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jun 2026 · NCT06835569Autologous CAR-T Cells Targeting B7-H3 in PDAC
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 jun 2026 · NCT06158139Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Duke Cancer Center, Durham
- Carolina BioOncology Institute, Huntersville
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 jun 2026 · NCT06040541Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- Southeastern Medical Oncology Center-Jacksonville, Jacksonville
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 may 2026 · NCT06998940Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 abr 2026 · NCT06483555Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- Carolina BioOncology Institute, Huntersville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 feb 2026 · NCT07030257A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Charlotte
- Ohio State University-Telemedicine, Raleigh
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 feb 2026 · NCT06906562Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
- University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill
ReclutandoFase 2
Edades de 18 a 99 · Todos los sexos · Actualizado el 13 ene 2026 · NCT03977233SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
- Levine Cancer Institute, Charlotte
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 ago 2025 · NCT04429542APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- University of North Carolina, Chapel Hill
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jun 2025 · NCT03175224Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 mar 2025 · NCT05776524De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.